Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.60 | €10.08 | 529.875% |
| Twist Bioscience Corp | 7 | 0 | 0 | 0 | €38.80 | €41.41 | 6.724% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.85 | €26.01 | 31.048% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €121.00 | €130.44 | 7.800% |
| XOMA Corp. | 6 | 0 | 0 | 0 | €21.80 | €68.78 | 215.501% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.50 | €8.75 | 16.667% |
| Geron Corp. | 12 | 0 | 0 | 0 | €3.50 | €4.63 | 32.090% |
| Corcept Therapeutics Inc. | 11 | 0 | 0 | 0 | €25.04 | €35.43 | 41.491% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.96 | - | - |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.00 | €100.00 | 20.482% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 0 | 0 | €0.98 | €2.78 | 183.400% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.44 | €38.19 | 96.469% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.93 | €5.51 | 493.606% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.40 | €50.00 | 26.904% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.54 | €4.00 | 57.480% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.40 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Pfizer Inc. | 31 | 4 | 0 | 0 | €25.98 | €41.10 | 58.241% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €61.15 | €86.77 | 41.899% |
| G1 Therapeutics | 15 | 1 | 0 | 0 | €4.46 | €10.56 | 136.643% |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |